PRINTBIO

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 09 Jul 2024 filing date already counts against anyone who files later.

Record

Serial number

98638778

Mark type

Stylized text

Filed

09 Jul 2024

Published for opposition

24 Mar 2026

Attorney of record

Jared L. DuJack

Goods and services

• Class 001 — Chemicals: Collagen for scientific and research use
• Class 003 — Cosmetics and cleaning preparations: Collagen preparations for cosmetic purposes
• Class 005 — Pharmaceuticals: Bioprinted organs comprising primarily living tissue for medical use; Bioprinted organs, namely, ears comprising primarily living tissue for medical use; Bioprinted organs, namely, livers comprising primarily living tissue for medical use; Bioprinted organs, namely, kidneys comprising primarily living tissue for medical use; Bioprinted organs, namely, portions of ears comprising primarily living tissue for medical use; Bioprinted organs, namely, portions of livers comprising primarily living tissue for medical use; Bioprinted organs, namely, portions of kidneys comprising primarily living tissue for medical use; Autologous bioprinted organs comprising primarily living tissue for medical use; Autologous bioprinted organs, namely, ears comprising primarily living tissue for medical use; Autologous bioprinted organs, namely, livers comprising primarily living tissue for medical use; Autologous bioprinted organs, namely, kidneys comprising primarily living tissue for medical use; Autologous bioprinted organs, namely, portions of ears comprising primarily living tissue for medical use; Autologous bioprinted organs, namely, portions of livers comprising primarily living tissue for medical use; Autologous bioprinted organs, namely, portions of kidneys comprising primarily living tissue for medical use; Bioprinted structures for organs comprising primarily living tissue for medical use; Autologous bioprinted structures for organs comprising primarily living tissue for medical use; Ink for 3D bioprinters comprising primarily living cells or other biological materials for medical purposes; Implantable protective shells comprising primarily living tissue; Implantable structural support devices comprising primarily living tissue; Implantable bioprinted exoskeletons comprising primarily living tissue; Implantable 3D bioprinted exoskeletons comprising primarily living tissue; Bioprinted surgical mesh comprising primarily living tissue; Bioresorbable surgical mesh comprising primarily living tissue; Bioprinted bioresorbable surgical mesh comprising primarily living tissue; Collagen for medical purposes; Collagen for medical purposes, namely, wound healing
• Class 007 — Machines and machine tools: 3D bioprinters; 6-axis 3D bioprinters
• Class 010 — Medical apparatus: Implants and mesh made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; Implantable protective shells composed of synthetic material; Implantable structural support devices composed of synthetic material; Bioprinted organs comprising primarily synthetic material for medical use; Bioprinted organs, namely, ears comprising primarily synthetic material for medical use; Bioprinted organs, namely, livers comprising primarily synthetic material for medical use; Bioprinted organs, namely, kidneys comprising primarily synthetic material for medical use; Bioprinted organs, namely, portions of ears comprising primarily synthetic material for medical use; Bioprinted organs, namely, portions of livers comprising primarily synthetic material for medical use; Bioprinted organs, namely, portions of kidneys comprising primarily synthetic material for medical use; Autologous bioprinted organs comprising primarily synthetic material for medical use; Autologous bioprinted organs, namely, ears comprising primarily synthetic material for medical use; Autologous bioprinted organs, namely, livers comprising primarily synthetic material for medical use; Autologous bioprinted organs, namely, kidneys comprising primarily synthetic material for medical use; Autologous bioprinted organs, namely, portions of ears comprising primarily synthetic material for medical use; Autologous bioprinted organs, namely, portions of livers comprising primarily synthetic material for medical use; Autologous bioprinted organs, namely, portions of kidneys comprising primarily synthetic material for medical use; Bioprinted structures for organs comprising primarily synthetic material for medical use; Autologous bioprinted structures for organs comprising primarily synthetic material for medical use; Ink for 3D bioprinters comprising primarily synthetic material or other materials for medical purposes; Implantable protective shells comprising primarily synthetic material; Implantable structural support devices comprising primarily synthetic material; Implantable bioprinted exoskeletons comprising primarily synthetic material; Implantable 3D bioprinted exoskeletons comprising primarily synthetic material; Bioprinted surgical mesh comprising primarily synthetic material; Bioresorbable surgical mesh comprising primarily synthetic material; Bioprinted bioresorbable surgical mesh comprising primarily synthetic material
• Class 044 — Medical, beauty and agricultural services: Medical services, namely, organ replacement therapy; Medical services, namely, organ replacement therapy using 3D bioprinting; Medical services, namely, organ replacement therapy using autologous bioprinting; Medical services, namely, on demand organ replacement therapy; Medical services, namely, on demand organ replacement therapy using 3D bioprinting; Medical services, namely, on demand organ replacement therapy using autologous bioprinting

Owner

• PrintBio, Inc., Surfside, FL, US
• PrintBio, Inc., Surfside, FL, US

Prosecution history

• 24 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 24 Mar 2026 — PUBLISHED FOR OPPOSITION
• 18 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 28 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 27 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 27 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 27 Feb 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
• 02 Dec 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
• 02 Dec 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
• 02 Sept 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 02 Sept 2025 — FINAL REFUSAL E-MAILED
• 02 Sept 2025 — FINAL REFUSAL WRITTEN
• 21 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 21 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 21 Aug 2025 — ASSIGNED TO LIE